↓ Skip to main content
Altmetric
What is this page?
Embed badge
Share
Share on Twitter
Share on Facebook
Share by email
Investigating the potential clinical benefit of Selumetinib in resensitising advanced iodine refractory differentiated thyroid cancer to radioiodine therapy (SEL-I-METRY): protocol for a multicentre…
Overview of attention for article published in BMC Cancer, June 2019
Altmetric Badge
About this Attention Score
In the top 25% of all research outputs scored by Altmetric
Good Attention Score compared to outputs of the same age (71st percentile)
Good Attention Score compared to outputs of the same age and source (76th percentile)
Mentioned by
policy
1
policy source
twitter
4
X users
peer_reviews
1
peer review site
facebook
1
Facebook page
Citations
dimensions_citation
31
Dimensions
Readers on
mendeley
44
Mendeley
Summary
Policy documents
X
Peer reviews
Facebook
Dimensions citations
So far, Altmetric has seen
1
peer review site that discusses this research output.
Publons
This paper has
1
review on Publons, an academic research evaluation site.
Review by Professor Dr. Sorush Niknamian
17 Jun 2019